|
"standl e"的相關文件
顯示項目 1-5 / 5 (共1頁)
1
每頁顯示[10|25|50]項目
| 國家衛生研究院 |
2025-02-07 |
Defining patient-reported outcomes in diabetes, obesity, cardiovascular disease, and chronic kidney disease for clinical practice guidelines - perspectives of the taskforce of the guideline workshop
|
Barnard-Kelly, K; Battelino, T; Brosius, FC; Ceriello, A; Cosentino, F; Gavin, JR, 3rd; Giorgino, F; Green, J; Ji, L; Kellerer, M; Koob, S; Kosiborod, M; Lalic, N; Marx, N; Nedungadi, P; Parkin, CG; Rodbard, HW; Rötzer, RD; Rydén, L; Sheu, WH; Standl, E; Jeppesen, BT; Topsever, P; Vandvik, PO; Wanner, C; Schnell, O |
| 國家衛生研究院 |
2024-05 |
Disparities in prevalence and treatment of diabetes, cardiovascular and chronic kidney diseases - Recommendations from the taskforce of the guideline workshop
|
Gavin, JR; Rodbard, HW; Battelino, T; Brosius, F; Ceriello, A; Cosentino, F; Giorgino, F; Green, J; Ji, L; Kellerer, M; Koob, S; Kosiborod, M; Lalic, N; Marx, N; Prashant Nedungadi, T; Parkin, CG; Topsever, P; Rydén, L; Sheu, WH, W; Standl, E; Olav Vandvik, P; Schnell, O |
| 國家衛生研究院 |
2023-10-13 |
Data from network meta-analyses can inform clinical practice guidelines and decision-making in diabetes management: Perspectives of the taskforce of the guideline workshop
|
Ceriello, A; Rodbard, HW; Battelino, T; Brosius, F; Cosentino, F; Green, J; Ji, LN; Kellerer, M; Koob, S; Kosiborod, M; Lalic, N; Marx, N; Nedungadi, TP; Parkin, CG; Rydén, L; Sheu, WHH; Standl, E; Vandvik, PO; Schnell, O; the Taskforce of the Guideline Workshop |
| 臺大學術典藏 |
2021-03-11T04:29:46Z |
Predictors of cardiovascular events in a contemporary population with impaired glucose tolerance: An observational analysis of the Nateglinide and Valsartan in impaired glucose tolerance outcomes research (NAVIGATOR) trial
|
Preiss D.; Thomas L.E.; Sun J.-L.; Haffner S.M.; Holman R.R.; Standl E.; Leiter L.A.; Mazzone T.; Rutten G.E.; Tognoni G.; Martinez F.A.; FU-TIEN CHIANG; Califf R.M.; McMurray J.J. |
| 臺大學術典藏 |
2021-03-11T04:29:42Z |
Predictors of stroke in patients with impaired glucose tolerance: Results from the nateglinide and valsartan in impaired glucose tolerance outcomes research trial
|
Preiss D.; Giles T.D.; Thomas L.E.; Sun J.-L.; Haffner S.M.; Holman R.R.; Standl E.; Mazzone T.; Rutten G.E.; Tognoni G.; FU-TIEN CHIANG; McMurray J.J.V.; Califf R.M. |
顯示項目 1-5 / 5 (共1頁)
1
每頁顯示[10|25|50]項目
|
